Abbott and NIH Join Forces to Advance Neuroscience Research

Abbott Laboratories and the National Institutes of Health have formed an alliance to evaluate applications that could help treat chronic pain and progressive movement disorders, like Parkinson’s disease. The collaboration is a part of NIH’s BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. The agreement specifically calls for NIH to use the Abbott Park, IL-based company’s neuromodulation technologies for research related to these NIH initiatives to explore their application for chronic pain and progressive movement disorders, like Parkinson’s disease. The BRAIN Initiative was launched in 2013 and looks to understand the functions of the human brain by researching and developing new uses for innovative technologies. Recently, the BRAIN Initiative assembled participants from contributing federal agencies, non-federal organizations, as well as members of the media, public, and Congress at its 5th Annual Investigators Meeting in Washington, D.C. The meeting provided a forum for discussing recent scientific developments and potential new directions in brain research and identified areas for collaboration and research coordination. “For Abbott this is a golden opportunity,” Binith Cheeran, Medical Director in Abbott’s Neuromodulation, told MD+DI. “We want to...
Source: MDDI - Category: Medical Devices Authors: Tags: R & D Source Type: news